Hughes N C, Phillips D H
Chester Beatty Laboratories, Institute of Cancer Research, London, UK.
Carcinogenesis. 1990 Sep;11(9):1611-9. doi: 10.1093/carcin/11.9.1611.
Several well-documented examples of human exposure to carcinogens involve complex mixtures of polycyclic aromatic hydrocarbons (PAHs). Although the biological properties of many pure PAHs have been investigated, less is known about their effects when present as components of mixtures. As the ability to form DNA adducts in vivo is generally indicative of carcinogenic activity of PAHs, we have compared the DNA binding potencies of dibenzo[a,e]pyrene (DB[a,e]P), dibenzo[a,e]pyrene (DB[a,h]P), dibenzo[a,i]pyrene (DB[a,i]P), dibenzo[a,l]pyrene (DB[a,l]P) and benzo[a]pyrene (B[a]P), when applied topically, either singly or in combination, to the skin of male Parkes mice. DNA isolated from the skin and lungs was analysed by 32P-postlabelling. The adducts formed by each PAH exhibited markedly different chromatographic mobilities on polyethyleneimine-cellulose TLC plates. The relative binding potencies of the compounds in both skin and lungs were: DB[a,l]P much greater than B[a]P greater than DB[a,h]P greater than DB[a,i]P greater than DB[a,e]P, in good agreement with their reported carcinogenicities in mouse skin. The majority of adducts were removed from DNA within 21 days of treatment, but low levels of adducts were found to persist for at least 3 months in both tissues. When DB[a,l]P, DB[a,e]P and B[a]P were applied together to mouse skin, a total binding 31% lower than expected was detected, while with a mixture of DB[a,e]P and B[a]P the binding to DNA in skin was 65% higher than expected from the binding levels of the carcinogens when applied singly. Other binary combinations of these three PAHs gave adduct levels similar to the sum of the binding levels of the individual components when applied singly. The results demonstrate the usefulness of 32P-post-labelling for the assessment of the DNA binding potencies of PAHs in mouse tissues, and for the detection of interactions between components of mixtures of carcinogens.
人类接触致癌物的几个有充分文献记载的例子涉及多环芳烃(PAH)的复杂混合物。尽管已经对许多纯PAH的生物学特性进行了研究,但对于它们作为混合物成分时的影响却知之甚少。由于在体内形成DNA加合物的能力通常表明PAH具有致癌活性,我们比较了二苯并[a,e]芘(DB[a,e]P)、二苯并[a,h]芘(DB[a,h]P)、二苯并[a,i]芘(DB[a,i]P)、二苯并[a,l]芘(DB[a,l]P)和苯并[a]芘(B[a]P)单独或组合局部应用于雄性帕克斯小鼠皮肤时的DNA结合能力。通过32P后标记分析从皮肤和肺中分离的DNA。每种PAH形成的加合物在聚乙烯亚胺-纤维素TLC板上表现出明显不同的色谱迁移率。化合物在皮肤和肺中的相对结合能力为:DB[a,l]P远大于B[a]P大于DB[a,h]P大于DB[a,i]P大于DB[a,e]P,这与它们在小鼠皮肤中报道的致癌性非常一致。大多数加合物在处理后21天内从DNA中去除,但在两个组织中都发现低水平的加合物至少持续3个月。当DB[a,l]P、DB[a,e]P和B[a]P一起应用于小鼠皮肤时,检测到的总结合比预期低31%,而当DB[a,e]P和B[a]P混合时,皮肤中与DNA的结合比单独应用致癌物时的结合水平高65%。这三种PAH的其他二元组合产生的加合物水平与单独应用时各成分结合水平的总和相似。结果证明了32P后标记在评估PAH在小鼠组织中的DNA结合能力以及检测致癌物混合物成分之间相互作用方面的有用性。